altRx review

A low recurring price with a consequential exit policy

AltRx is worth comparing for its published treatment price, but the decision should begin with two facts together. It lists compounded semaglutide at $89 a month and tirzepatide at $149, with the consultation, injection supplies and shipping included. FDA also issued warning letter 728236 to Trinity HealthCare Supply, LLC dba altRx. The letter identifies this operator and altRx's website directly.

The price pages say the amount stays the same at every dose and advertise no separate membership fee. That makes the published monthly amount more useful for budgeting than a low starter-dose quote with an undisclosed maintenance ladder. It does not establish that every patient is eligible, that every formulation is appropriate, or that a prescription will be issued. Treat the consultation as a medical assessment rather than a promise to obtain a particular product.

Read the refund rule before choosing a plan

The refund policy is more restrictive than the phrase “cancel anytime” might suggest. The policy says subscription payments are final and non-refundable at purchase, with an exception for medical disqualification covering the unused portion of the term. It also says multi-month plans are not refundable in whole or in part. These terms matter even when the recurring amount looks affordable: paying for more time can expose more money to the same restriction.

Cancellation requires at least 72 hours before the next billing date, using email, telephone or the portal. Stopping a future renewal is therefore a different question from recovering a payment already made. Before authorizing payment, confirm the next charge date and whether your selected offer creates any prepaid commitment. A reminder several days before renewal is more useful here than assuming that a cancellation request instantly reverses an existing order.

What the company actually discloses

AltRx names several compounding pharmacies, including RedRock, Health Warehouse, Precision Medicine and Triad Rx, with addresses on its pharmacy list. Clinical services are attributed to OpenLoop Healthcare Partners and affiliated practices, while the platform describes an administrative role. That separation helps identify whom to ask about prescribing, dispensing and billing. A named pharmacy is useful accountability information; it does not make the compounded medication FDA-approved.

Its brand Wegovy and Zepbound pages list prices at $1,579 and $1,249 a month respectively. Those are distinct branded offers, not equivalent prices for the compounded plans. The business relationship around Trinity also needs precision: the documented Trinity trademark connection involves Trinity HealthCare Supply LLC, while Trinity’s current service agreement names Trinity Meds Inc. That brand connection should not be stretched into a claim that every named entity is legally identical.

Who should pause before enrolling

Its public pages do not provide pregnancy, breastfeeding or PCOS guidance specific enough to support choosing altRx for maternal expertise. Its all-state availability claim is qualified by provider licensing and the state-dependent choice between video and asynchronous review. Confirm the treatment available at your address rather than treating nationwide marketing as an individual eligibility decision.

This option is easiest to assess for someone who wants a disclosed flat treatment price and can accept the payment and cancellation terms. Someone who values refundable unused treatment, a named maternal-care pathway or more flexible financial exposure has reasons to keep comparing. Read our comparison guide using the full recurring cost, and treat the FDA letter and the exit policy as separate decisions rather than allowing the low price to answer either one.